About this trial
This study will evaluate implementation strategies to address barriers and increase uptake of PrEP among Black cisgender women in Planned Parenthood of Illinois (PPIL) health centers.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Eligible participants include ciswomen presenting at a PPIL health center with a positive STI test (syphilis, gonorrhea, or chlamydia) and identified in the EHR using STI testing records and new fields for optimizing support of provider PrEP counseling.
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
POWER Up strategies -
BehavioralClinics will implement adapted POWER Up intervention strategies when a patient is flagged as PrEP eligible.
Treatment groups
Trial outcomes
Primary outcomes
PrEP prescriptions among Black women accessing PPIL services and eligible for PrEP.
PrEP eligibility among Black women will be defined based on positive STI test and identified in the EHR using STI testing records and new fields for optimizing support of provider PrEP counseling. Using de-identified patient-level EHR data for eligible women at each clinic within each time point, we will create a dichotomous variable for having received a prescription for PrEP during a given time period.
Secondary outcomes
Receipt of PrEP refills among Black women accessing FP services at 6 months.
Using de-identified patient-level EHR data for eligible patients at each clinic within each time point, we will create a dichotomous variable for receiving refills of prescriptions for PrEP of those with an initial PrEP prescription.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Rush University Medical Center
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
University of Illinois at Chicago
Collaborator
Planned Parenthood of Illinois
Collaborator
This trial is not recruiting at the moment. You can still explore other options: